IRIS Kinetics Unveils Point-of-Care Kinetic Biosensing Platform
The IRIS TX-100 uses cartridge-based technology to measure up to 100 biomarkers in approximately 10 minutes.
Read MorePosted by CLP Edit Staff | Jul 27, 2026 | Company News, Diagnostic Technologies |
The IRIS TX-100 uses cartridge-based technology to measure up to 100 biomarkers in approximately 10 minutes.
Read MorePosted by CLP Edit Staff | Jul 27, 2026 | Infectious Diseases, Molecular Diagnostics, Sexually Transmitted Diseases |
The funding will support regulatory certification and the commercial launch of rapid tests for Lyme disease and sexually transmitted infections.
Read MorePosted by CLP Edit Staff | Jul 21, 2026 | Sexually Transmitted Diseases |
The NIH has awarded $1.3 million to UMass Amherst’s Chang Liu to develop an at-home HIV test with lab-comparable sensitivity, aiming to improve early diagnosis and address diagnostic barriers in resource-limited settings.
Read MorePosted by CLP Edit Staff | Jul 7, 2026 | Emerging & Zoonotic Diseases |
WHO has added the first molecular diagnostic test for Ebola Bundibugyo virus to its Emergency Use Listing, aiming to support rapid infection confirmation and surveillance during the ongoing outbreak in Central Africa.
Read MorePosted by CLP Edit Staff | Jul 7, 2026 | Sexually Transmitted Diseases |
A randomized trial found Cepheid’s Xpert Xpress MVP test improved appropriate treatment rates for vaginitis within 24 hours compared to standard diagnostic methods.
Read More